Canaccord Genuity Maintains a 'Buy' on Vical (VICL); Still Attractive Risk/Reward
Tweet
Share
E-mailGet Alerts VICL Hot Sheet
Price: $0.68 --0%
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
3 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Vical (NASDAQ: VICL) price target of $8.00.
Analsyt, George Farmer, said, "Pushed out again, management sees overall survival data from the Phase III registration trial evaluating A-7 in metastatic melanoma reporting Q4/12, or about 33 months since last patient enrolled. We regard this development as neutral to positive for handicapping likelihood of trial success...A positive trial outcome could send shares into the high teens with ultimate take-out potential almost certain, in our view. We see more limited downside given value supported by potential of TransVax for CMV prophylaxis in bone marrow transplant patients."
For an analyst ratings summary and ratings history on Vical click here. For more ratings news on Vical click here.
Shares of Vical closed at $3.68 yesterday.
Analsyt, George Farmer, said, "Pushed out again, management sees overall survival data from the Phase III registration trial evaluating A-7 in metastatic melanoma reporting Q4/12, or about 33 months since last patient enrolled. We regard this development as neutral to positive for handicapping likelihood of trial success...A positive trial outcome could send shares into the high teens with ultimate take-out potential almost certain, in our view. We see more limited downside given value supported by potential of TransVax for CMV prophylaxis in bone marrow transplant patients."
For an analyst ratings summary and ratings history on Vical click here. For more ratings news on Vical click here.
Shares of Vical closed at $3.68 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Revolution (RVMD) PT Raised to $179 at Bernstein SocGen Group
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
